BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20711425)

  • 1. RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies.
    McNerny DQ; Kukowska-Latallo JF; Mullen DG; Wallace JM; Desai AM; Shukla R; Huang B; Banaszak Holl MM; Baker JR
    Bioconjug Chem; 2009 Oct; 20(10):1853-9. PubMed ID: 20711425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor-PEG functionalized PAMAM-pentaethylenehexamine dendron for targeted gene delivery produced by click chemistry.
    Yu H; Nie Y; Dohmen C; Li Y; Wagner E
    Biomacromolecules; 2011 Jun; 12(6):2039-47. PubMed ID: 21491906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonionic, water self-dispersible "hairy-rod" poly(p-phenylene)-g-poly(ethylene glycol) copolymer/carbon nanotube conjugates for targeted cell imaging.
    Yuksel M; Colak DG; Akin M; Cianga I; Kukut M; Medine EI; Can M; Sakarya S; Unak P; Timur S; Yagci Y
    Biomacromolecules; 2012 Sep; 13(9):2680-91. PubMed ID: 22866988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin αvβ3-Specific Hydrocyanine for Cooperative Targeting of Glioblastoma with High Sensitivity and Specificity.
    Zhang L; Meng X; Shan X; Gu T; Zhang J; Feng S; An X; Chen J; Jiang Q; Ning X
    Anal Chem; 2019 Oct; 91(19):12587-12595. PubMed ID: 31496223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells.
    Chang MW; Lo JM; Juan HF; Chang HY; Chuang CY
    PLoS One; 2012; 7(5):e37935. PubMed ID: 22655084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.
    Cheng Z; Wu Y; Xiong Z; Gambhir SS; Chen X
    Bioconjug Chem; 2005; 16(6):1433-41. PubMed ID: 16287239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
    Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
    Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.
    Zheng Y; Ji S; Czerwinski A; Valenzuela F; Pennington M; Liu S
    Bioconjug Chem; 2014 Nov; 25(11):1925-41. PubMed ID: 25312799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma.
    Waite CL; Roth CM
    Bioconjug Chem; 2009 Oct; 20(10):1908-16. PubMed ID: 19775120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting alphavbeta3 integrins.
    Lesniak WG; Kariapper MS; Nair BM; Tan W; Hutson A; Balogh LP; Khan MK
    Bioconjug Chem; 2007; 18(4):1148-54. PubMed ID: 17566976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment.
    Kiessling F; Huppert J; Zhang C; Jayapaul J; Zwick S; Woenne EC; Mueller MM; Zentgraf H; Eisenhut M; Addadi Y; Neeman M; Semmler W
    Radiology; 2009 Nov; 253(2):462-9. PubMed ID: 19789239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin alphaVbeta3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly(ethylene imine).
    Merkel OM; Germershaus O; Wada CK; Tarcha PJ; Merdan T; Kissel T
    Bioconjug Chem; 2009 Jun; 20(6):1270-80. PubMed ID: 19476331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis.
    Lee J; Lee TS; Ryu J; Hong S; Kang M; Im K; Kang JH; Lim SM; Park S; Song R
    J Nucl Med; 2013 Jan; 54(1):96-103. PubMed ID: 23232276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
    Mathejczyk JE; Pauli J; Dullin C; Napp J; Tietze LF; Kessler H; Resch-Genger U; Alves F
    Mol Imaging; 2011 Dec; 10(6):469-80. PubMed ID: 22201538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy study.
    Kang W; Svirskis D; Sarojini V; McGregor AL; Bevitt J; Wu Z
    Oncotarget; 2017 May; 8(22):36614-36627. PubMed ID: 28402271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.
    Eldar-Boock A; Blau R; Ryppa C; Baabur-Cohen H; Many A; Vicent MJ; Kratz F; Sanchis J; Satchi-Fainaro R
    J Drug Target; 2017; 25(9-10):829-844. PubMed ID: 28737432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of RGD-Containing Cyclic Peptides against αvβ3 Integrin.
    Wang Y; Xiao W; Zhang Y; Meza L; Tseng H; Takada Y; Ames JB; Lam KS
    Mol Cancer Ther; 2016 Feb; 15(2):232-40. PubMed ID: 26719578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.